Literature DB >> 27760779

Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents.

Wei-Ju Lee1, Eng-Yen Huang2, Chih-Min Tsai1, Kuang-Che Kuo1, Yi-Chuan Huang1, Kai-Sheng Hsieh1, Chen-Kuang Niu1, Hong-Ren Yu3.   

Abstract

Mycoplasma pneumoniae is an important causative pathogen of community-acquired pneumonia in children. Rapid and reliable laboratory diagnosis of M. pneumoniae infection is important so that appropriate antibiotic treatment can be initiated to reduce the misuse of drugs and resistance rates. Anti-M. pneumoniae immunoglobulin M (IgM) is an indicator of recent primary infection but can persist for several months after initial infection. It has been suggested that anti-M. pneumoniae immunoglobulin A (IgA) can be a reliable indicator for recent M. pneumoniae infection in adults. We investigated the clinical diagnostic value of M. pneumoniae IgA in school-age children and adolescents with M. pneumoniae-related pneumonia. Eighty children with pneumonia and seropositive for M. pneumoniae IgM or with a 4-fold increase of anti-M. pneumoniae immunoglobulin G (IgG) were enrolled from May 2015 to March 2016. The titers of M. pneumoniae IgA, IgM, and IgG, the clinical features, and laboratory examinations of blood, C-reactive protein, and liver enzymes were analyzed. The initial positivity rates for M. pneumoniae IgM and IgA upon admission to the hospital were 63.6 and 33.8%, respectively. One week after admission, the cumulative positivity rates for M. pneumoniae IgM and IgA increased to 97.5 and 56.3%, respectively. Detection of M. pneumoniae IgM was more sensitive than detection of M. pneumoniae IgA for the diagnosis of M. pneumoniae-related pneumonia in school-age children and adolescents; however, paired sera are necessary for a more accurate diagnosis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Mycoplasma pneumoniae IgA; Mycoplasma pneumoniae IgM; mycoplasma pneumonia IgA; mycoplasma pneumonia IgM; paired sera; pneumonia; school-age children

Mesh:

Substances:

Year:  2017        PMID: 27760779      PMCID: PMC5216438          DOI: 10.1128/CVI.00471-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia.

Authors:  T Watkins-Riedel; G Stanek; F Daxboeck
Journal:  Diagn Microbiol Infect Dis       Date:  2001 May-Jun       Impact factor: 2.803

2.  The use of systemic and topical fluoroquinolones.

Authors:  John S Bradley; Mary Anne Jackson
Journal:  Pediatrics       Date:  2011-09-26       Impact factor: 7.124

3.  Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children.

Authors:  Tsutomu Yamazaki; Mitsuo Narita; Nozomu Sasaki; Tsuyoshi Kenri; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Clin Vaccine Immunol       Date:  2006-06

4.  Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction-based test for Mycoplasma pneumoniae.

Authors:  M Reznikov; T K Blackmore; J J Finlay-Jones; D L Gordon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

Review 5.  Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children.

Authors:  J B Gavranich; A B Chang
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and mu-capture IgM methods.

Authors:  M Granström; T Holme; A M Sjögren; A Ortqvist; M Kalin
Journal:  J Med Microbiol       Date:  1994-04       Impact factor: 2.472

7.  Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.

Authors:  J W Dorigo-Zetsma; S A Zaat; P M Wertheim-van Dillen; L Spanjaard; J Rijntjes; G van Waveren; J S Jensen; A F Angulo; J Dankert
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Comparison of real-time polymerase chain reaction and serological tests for the confirmation of Mycoplasma pneumoniae infection in children with clinical diagnosis of atypical pneumonia.

Authors:  Hsin-Yu Chang; Luan-Yin Chang; Pei-Lan Shao; Ping-Ing Lee; Jong-Min Chen; Chin-Yun Lee; Chun-Yi Lu; Li-Min Huang
Journal:  J Microbiol Immunol Infect       Date:  2013-05-29       Impact factor: 4.399

9.  Early Serologic Diagnosis of Mycoplasma pneumoniae Pneumonia: An Observational Study on Changes in Titers of Specific-IgM Antibodies and Cold Agglutinins.

Authors:  Sung-Churl Lee; You-Sook Youn; Jung-Woo Rhim; Jin-Han Kang; Kyung-Yil Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Evaluation of 10 serological assays for diagnosing Mycoplasma pneumoniae infection.

Authors:  Laurent Busson; Sigi Van den Wijngaert; Hafid Dahma; Marc Decolvenaer; Lina Di Cesare; Agnes Martin; Liesbet Vasseur; Olivier Vandenberg
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-26       Impact factor: 2.803

View more
  14 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Early Diagnosis of Mycoplasma pneumoniae in Children: Simultaneous Amplification and Testing (SAT) Is the Key.

Authors:  Jieqiong Li; Lin Sun; Xirong Wu; Yan Guo; Weiwei Jiao; Jing Xiao; Baoping Xu; Adong Shen
Journal:  Front Pediatr       Date:  2019-10-25       Impact factor: 3.418

3.  Serological diagnosis of Mycoplasma pneumoniae infection by using the mimic epitopes.

Authors:  Wenyuan Shi; Lanhua Zhao; Shengtao Li; Guizhen Xu; Yanhua Zeng
Journal:  World J Microbiol Biotechnol       Date:  2018-05-29       Impact factor: 3.312

4.  Hepatocyte growth factor can guide treatment of Mycoplasma pneumoniae pneumonia in children.

Authors:  Lun Qin Liu; Zhi Hua Wang; Hai Yun Yao
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

5.  Evaluation of IgM Lateral Flow Assay as a Screening Tool for Mycoplasma pneumoniae Infection in Childhood Pneumonia.

Authors:  Patrick M Meyer Sauteur; Elena Pánisová; Lucas M Bachmann; Lilliam Ambroggio; Christoph Berger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

6.  The diagnostic value of serological tests and real-time polymerase chain reaction in children with acute Mycoplasma pneumoniae infection.

Authors:  Qing-Ling Li; He-Ting Dong; Hui-Ming Sun; Xin-Xing Zhang; Wen-Jing Gu; Li Huang; Yu-Qing Wang; Yong-Dong Yan; Wei Ji; Chuang-Li Hao; Can-Hong Zhu; Zheng-Rong Chen
Journal:  Ann Transl Med       Date:  2020-03

7.  Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells.

Authors:  Patrick M Meyer Sauteur; Michelle Seiler; Johannes Trück; Wendy W J Unger; Paolo Paioni; Christa Relly; Georg Staubli; Thorsten Haas; Claudine Gysin; Lucas M Bachmann; Annemarie M C van Rossum; Christoph Berger
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

8.  Highly homogeneous microbial communities dominated by Mycoplasma pneumoniae instead of increased resistance to macrolide antibiotics is the characteristic of lower respiratory tract microbiome of children with refractory Mycoplasma pneumoniae pneumonia.

Authors:  Jinglong Chen; Zhimin Xi; Yanyan Shi; Lijuan Liu; Libo Wang; Liling Qian; Aizhen Lu
Journal:  Transl Pediatr       Date:  2021-03

9.  Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients.

Authors:  Mingshan Xue; Teng Zhang; Haisheng Hu; Zhifeng Huang; Yingjie Zhen; Yueting Liang; Yifeng Zeng; Tengchuan Jin; Luqian Zhou; Xiaohua D Zhang; Baoqing Sun
Journal:  J Med Virol       Date:  2020-09-30       Impact factor: 20.693

10.  Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models.

Authors:  Shanshan Guo; Lei Bao; Tiange Qu; Xin Mao; Yingjie Gao; Yingli Xu; Xiaolan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.